IMRIS in partnership with Siemens Healthineers, announced a strengthened collaboration, enabling both companies to leverage their areas of expertise to advance in the growing multimodality hybrid OR neurosurgical market. IMRIS will support the sales of both the IMRIS ceiling-mounted and Siemens Healthineers fixed options for MRI, CT and Angiography imaging modalities.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
53.11 EUR | +0.63% | +2.00% | +0.84% |
10:00am | SIEMENS HEALTHINEERS : Jefferies gives a Buy rating | ZD |
09/05 | SIEMENS HEALTHINEERS : Bernstein remains its Buy rating | ZD |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.84% | 6.36TCr | |
+10.98% | 23TCr | |
+9.31% | 19TCr | |
+13.10% | 14TCr | |
+25.86% | 11TCr | |
+5.62% | 5.13TCr | |
+12.36% | 5.1TCr | |
+7.15% | 4.33TCr | |
+5.24% | 3.7TCr | |
+26.47% | 3.2TCr |
- Stock Market
- Equities
- SHL Stock
- News Siemens Healthineers AG
- IMRIS, Siemens Healthineers to Strengthen Collaboration for the Growing Hybrid OR Neurosurgical Market